Cumberland Pharmaceuticals Inc logo

Cumberland Pharmaceuticals Inc

CPIX · NASDAQ · Health Technology, Pharmaceuticals Major · Founded 1999

Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which focuses on the acquisition, development, and commercialization of branded prescription pharmaceutical products. It operates through the following geographical segments: China, South Korea, Russia, Mexico, Australia, and Saudi Arabia. The firm products include Acetadote, Caldolor, Kristalose, Vaprisol, Talicia, Vibativ, Sancuso, Omeclamox, RediTrex, and Other. The company was founded by A. J. Kazimi on January 7, 1999 and is headquartered in Nashville, TN.

Current Price
$4.35
Market Cap
$73.0M
Return Since Last Split
-67%
Last Split
Jul 6, 2007
Total Splits
1
Cumulative Multiple
2×

What If You Bought CPIX Earlier?

Investment
Purchase Date (Before Split)
Worth Today
$870
200 shares · 2×

Estimate based on split history only. Excludes dividends, fees, taxes, and intraday movement.

Stock Split History

Newest split first. Cumulative multiple = compounded growth from that date to today.

Split DatePrice BeforeRatioSplit MultipleCumulative
Jul 6, 2007—2-for-12×2×

Cumberland Pharmaceuticals Inc Market Cap Timeline

Validated annual market-cap history is available from 2009. Split markers cover all 1 recorded split. Filled dots have market-cap data for that year; hollow dots mark split years outside market-cap source coverage.

Frequently Asked Questions

Cumberland Pharmaceuticals Inc's latest record in the split calendar is a 2-for-1 forward split effective 2007-07-06.
Stay in the loop

Never Miss a Stock Split Again

Get personalized stock split alerts. Choose what you receive and how often.

Your email is securely stored. We’ll only contact you about updates you choose. Unsubscribe anytime.